deltatrials
Completed PHASE4 NCT00589927

Triple Versus Dual Antiplatelet Therapy After ABT578-Eluting Stent

Comparison of Triple Versus Dual Antiplatelet Therapy After ABT578-Eluting Stent Implantation For Long Coronary Lesions

Sponsor: CardioVascular Research Foundation, Korea

Conditions Coronary Artery Disease
Interventions cilostazol placebo
Updated 6 times since 2017 Last updated: Mar 17, 2010 Started: Dec 31, 2007 Primary completion: Dec 31, 2009 Completion: Feb 28, 2010

A PHASE4 clinical study on Coronary Artery Disease, this trial is completed. The trial is conducted by CardioVascular Research Foundation, Korea and has accumulated 6 data snapshots since 2007. Cardiovascular trials of this type often inform treatment guidelines for long-term patient management.

Change History

6 versions recorded

  1. Sep 2025 — Present [monthly]

    Completed PHASE4

  2. Sep 2024 — Sep 2025 [monthly]

    Completed PHASE4

  3. Jul 2024 — Sep 2024 [monthly]

    Completed PHASE4

  4. Jan 2021 — Jul 2024 [monthly]

    Completed PHASE4

  5. Jun 2018 — Jan 2021 [monthly]

    Completed PHASE4

▶ Show 1 earlier version

  1. Jan 2017 — Jun 2018 [monthly]

    Completed PHASE4

    First recorded

Dec 2007

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • CardioVascular Research Foundation, Korea
  • Otsuka Korea
Data source: CardioVascular Research Foundation, Korea

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

  • • Bucheon-si, South Korea
  • • Cheonan, South Korea
  • • Chuncheon, South Korea
  • • Daejeon, South Korea
  • • Pyeongchon, South Korea
  • • Seoul, South Korea
  • • Ulsan, South Korea